Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease

详细信息    查看全文

• 作者：Davide Seripa ; Marilisa Franceschi ; Grazia D’ ; Onofrio ; Francesco Panza ; Le ; ro Cascavilla ; Francesco Paris ; Giuliana Placentino ; Maria Giovanna Matera ; Vincenzo Solfrizzi ; Alberto Pilotto
• 关键词：5-Hydroxytriptamine (5HT) ; 5-Hydroxytriptamine transporter (5HTT) ; 5-Hydroxytriptamine transporter gene-linked polymorphic region (5HTTLPR) ; Polymorphism C ; Solute carrier family 6 (neurotransmitter transporter ; serotonin) member 4 (SLC6A4) ; Questionable
• 刊名：Neuroscience Letters
• 出版年：2008
• 出版时间：27 June 2008
• 年：2008
• 卷：438
• 期：3
• 页码：335-339
• 全文大小：144 K

文摘

The promoter region of the serotonin transporter gene (SLC6A4) shows a 22-bp tandem repeat polymorphism, indicated as polymorphism C, that has been associated to depression, obsessive-compulsive disorder, memory impairment, and anxiety. Less clear are data regarding its association with Alzheimer's disease (AD). No data were reported regarding its association with questionable dementia (QD). In this study we investigate for polymorphism C in the SLC6A4 gene 302 elderly subjects with a clinical diagnosis of AD (n = 105), QD (n = 88) and no cognitive impairment (n = 114) attending a geriatric ward. A community-dwelling sample of 390 healthy subjects was also included in the analysis. A significant higher prevalence of the C16/C16 genotype in AD than in QD was observed (37.14 % vs. 3 % ; p = 0.041, OR 2.001, 95 % CI 1.018–4.024), while no differences in the C16/C14 and C14/C14 genotypes as well as in the estimated allele frequencies were found. No further differences among the three groups of subjects were found, also when they were compared with the community-dwelling sample. These findings suggest that SLC6A4 gene variation may have only a minor role, if any, in AD or QD.